Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Double-Blind Parallel Group Sham-Controlled Study Evaluating the Efficacy and Safety of Non-invasive Non-repetitive Transcranial Magnetic Stimulation (TMS) for the Acute Preemptive Treatment of the Aura Phase of Migraine Headache

NCT00449540 is registered in ClinicalTrials.gov with Neuralieve as lead sponsor.

NCT NCT00449540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00449540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Double-Blind Parallel Group Sham-Controlled Study Evaluating the Efficacy and Safety of Non-invasive Non-repetitive Transcranial Magnetic Stimulation (TMS) for the Acute Preemptive Treatment of the Aura Phase of Migraine Headache
Lead sponsor
Neuralieve
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2006
Completion date
March 31, 2008
Enrollment
201 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

migraine with aura